Consumers should stop use and report any adverse events.
Rare instances of worsening liver function reported to FDA.
New results contradict HHS and FDA plans.
Grant-funded program to bring more opportunities for safe disposal.
50 new recommendations signed by organizations, schools, and regulators.
Update: ASHP statement released.
Blockchain technology will track intra- and inter- health care system medicine transfers.
Alvogen, Inc., has issued a recall of two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level.
Women no longer require nine months of contraception post cessation of the drug.